SCHEMBL25724155

SCHEMBL25724155

Cc1cc(F)c2[nH]ncc2c1C(C)(C)Cn1nc(N)c2c(C(C)(C)C)c(F)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18408663 0.73 MAPT (0.34) —
SCHEMBL22328049 0.73 METAP2 (0.33) —
SCHEMBL22924099 0.72 — —
SCHEMBL22924101 0.71 — —
SCHEMBL22924114 0.68 METAP2 (0.36) —
SCHEMBL24592387 0.66 — —
SCHEMBL22924128 0.62 — —
SCHEMBL24089316 0.62 — —
SCHEMBL22349086 0.62 KDR (0.37) —
SCHEMBL26522473 0.61 NOS1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203060-A1 FUSED TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2023-06-29 — — US disclosed
Send feedback